Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
109 Cards in this Set
- Front
- Back
Biorisk Management |
Organizational structure, policies, practices and biosafety guidance; Instituted and support by the management; Provides procedures and accountability |
|
Biorisk Management |
The combination of biosafety and biosecurity |
|
• Assessment • Mitigation • Performance |
AMP Model |
|
Assesstment |
Takes into account the adequacy of existing controls; Identifying the hazard and evaluating the risk associated; Deciding whether or not the risks are acceptable |
|
Risk Assessment |
Identify the specific hazard or threat; Determine the consequences of an identify risk; Identify all existing controls for any additional ones to be applied |
|
Mitigation |
Action and control measures put into place; To reduce or eliminate risk |
|
Elimination or Substitution |
Removing the hazard or replacing with something less dangerous |
|
Engineering Controls |
physical set up, equipment, material, facilities relevant to the work area environment that reduce or prevent exposure to hazard |
|
Administrative Control |
Policies, standard, guidelines used to control the risks |
|
Practices and Procedures |
processes and activities shown in practice to be effective in reducing risks |
|
PPE |
Deviced worn by the worker to protect against hazard |
|
Performance |
Implementation of entire biorisk management system; Evaluating and ensuring the system is working the way it was designed; Continually improving the system; Supervise and evaluate |
|
Clinical Lab Testing |
To gather information on patient health status; Ensure quality of work done |
|
1. Pre-Analytical 2. Analytical 3. Post-Analytical |
Testing Cycle |
|
Pre-Analytical |
Involves variables that occur prior actual testing; Specimen collection, test request, patient preparation |
|
Analytical |
Activities directly affecting actual testing; Test reagent, instrument, procedure, skills of MT |
|
Post-Analytical |
Activities affecting release, reporting, interpretation of test result |
|
Quality Control |
Concerned with analytical cycle of testing; Monitors accuracy and precision; Ensures correctness of test result; Quality and reliability |
|
Clinical Laboratory |
Where tests are performed on clinical specimens; Regard to diagnosis, treatment, prevention of disease |
|
Clinical Laboratory Law of 1966 |
Also known as Republic Act. No. 4688 |
|
Republic Act. No. 4688 |
A Republic act which ensures the health of the pubic; Prevent operation of substandard laboratories |
|
Clinical Pathology |
It includes hematology, clinical chemistry, microbiology, blood banking, toxicology, and drug monitoring |
|
Anatomical Pathology |
It includes surgical pathology, cytology, and autopsy |
|
Hospital-Based |
Type of institution that operates within a hospital |
|
Non-hospital based |
Type of institution that operates on its own |
|
Primary |
Type of service capability that operates routine examinations; Basic equipments; 10 sqm space |
|
Secondary |
Type of service capability that operates routine chemistry and basic blood bank test; Additional equipments; 20 sqm space |
|
Tertiary |
Type of service capability that operates special tests (chemistry, hematology, serology, microbiology); Additional equipments; 60 sqm space |
|
Pathologist |
Based on RA 5527; Registered physician, trained in methods of laboratory medicine, designated "head" of the clinical laboratory |
|
Medical Technologist |
Based on RA 5527; Person engaged in work of medical technology |
|
Medical Laboratory Technician |
Based on Ra 5527; Person qualified to assist a MT and/or Pathologist |
|
Phlebotomist |
Person trained to collect blood samples |
|
Clinical Chemistry |
Test for chemical components of blood and/or urine; Blood glucose, lipids, proteins, enzymes, and electrolytes |
|
Hematology |
Examination of complete blood count; Hemoglobin, hematocrit, RBC, WBC, platelets |
|
Microbiology |
Identification, cultivation of microorganism; Bacterial culture and sensitivity |
|
Clinical Microscopy |
Analysis of urine and other body fluids; Urine, semen, CSF, synovial fluid |
|
Parasitology |
Examination of stool and other body fluids; Parasites and parasitic infections; Check for the presence of parasite |
|
Serology |
Antigen and antibody reactions; Pregnancy, hepatitis, HIV tests |
|
Blood Banking |
Blood typing, cross-match, blood donation; Blood cell antigens and antibodies related to transfusion and transplant |
|
Histopathology |
Preparation, processing, handling; Slide preparation |
|
Substantial Procedural |
Procedure of scientific activities; Laboratory methods comprise scientific procedures |
|
Investigative Complicity |
Involves range of laboratory investigation; Inquiry on health problems |
|
Intermedical Procedural Interference |
"Clinical eye" in diagnosis and treatment; Intervention in medical procedures |
|
Assiduous Partner |
Application of science and technology; Techniques laid down by science and technology |
|
Circumstantial Medical Evidences |
Evidentiary Information in Medicine; Laboratory reports as proof of medical findings and prognosis |
|
RA 10912 |
Continuing Professional Development Act of 2016 (CPD Law) |
|
CPD |
Requires as mandatory for renewal of PRC ID |
|
RA 10912 |
Promote and upgrade/improve the professional in the country following the international standards of practice |
|
Local Provider |
CPD Provider based on PRC Resolution 1032; Individual sole proprietor, firm, partnership, corporation, government institution or agency |
|
Foreign Provider |
CPD Provider based on PRC Resolution 1032; Foreign entity, firm, association |
|
3 years |
CPD accreditation valid for __ year/s |
|
45 |
Apply for accreditation of seminar/training at least ___ day/s before actual conduct of program |
|
30 days |
Application for Accreditation processing period of CPD Provider |
|
45 days |
Application for Accreditation processing period of CPD Program |
|
60 days |
Application for Accreditation processing period of Self-Directed and/or Lifelong Learning |
|
45 points |
Points required of a Medical Technologist/MLS for the renewal of PIC |
|
Hippocrates |
Father of Medicine |
|
• Blood • Phlegm • Yellow Bile • Black Bile |
Four Humors of the Body |
|
Vivian Herrick |
Found evidence of parasitic infection in Ancient Egypt through her research on the Ebers Papyrus |
|
Ruth Williams |
Found evidence of urinalysis during Medieval period and use the appearance of urine to diagnose disease |
|
Anna Fagelson |
Suggested medical technology began in 14th century |
|
Alexander Gillani |
His death was from laboratory acquired infection |
|
Anton Van Leeuwenhoek |
Invented the first functional crude microscope; He described the appearance of red cells and bacteria |
|
Rudolf Virchow |
Father of Microscopic Pathology; Emphasis on the study of manifestation of disease and infections on cellular level |
|
Dr. Calvin Ellis |
First to examine specimens using a microscope |
|
Dr. William Occam |
Used laboratory findings as a evidence in diagnosing disease |
|
Baron Karl Von Humbeldt |
Used laboratory findings in the treatment of disease |
|
Dr. William Welch |
Opened a teaching laboratory at Bellevue Medical College (NYU Medical School); First professor of pathology at Johns Hopkins University |
|
Dr. William Osler |
Introduced and used the microscopic and a blood counting machine |
|
Dr. Douglas |
The founder of the largest and best equipped laboratory opened in the Univeristy of Michigan |
|
Insurance Act of 1911 |
An Act that state, the basis for diagnosing disease is laboratory Science |
|
26th Medical Laboratory of 6th Army |
They established the first clinical laboratory at Quiricada Street, Sta. Cruz Manila |
|
Dr. Pio De Roda |
Member of the 26th Medical Laboratory; Preserved the remains of the laboratory |
|
Dr. Mariano Icasiano |
He assisted Dr. Pio De Roda on the preservation of the remains of the laboratory |
|
Dr. Prudencio Sta. Anna and Dr. Tirso Briones |
They prepared a syllabus with a 6 month training course |
|
Dr. Willa Hilgert Hedrick |
Prepared a 5 years course curriculum in medical laboratory |
|
Mrs Antoinette McKelvey |
She assisted Dr. Hedrick in preparing the 5 years course |
|
Manila Health Sanitarium and Philippine Union College |
5 years course in medical technology first offered at ______ and _______ |
|
1962 |
The year Medical Laboratory Science offered by USA |
|
Professional Organization |
A particular profession; The interest of individual engaged in the profession; Public interests |
|
Philippine Association of Medical Technologists |
PAMET stands for |
|
Crisanto G. Almario |
Father of PAMET |
|
Charlemagne T. Tamondong |
First president of PAMET |
|
PASMETH |
Organization of all registered schools of medical technology in the Philippined |
|
Philippine Association of Schools of Medical Technology and Public Health |
PASMETH stands for |
|
Ethics |
Views happenings, events, decisions as products of right thoughts and deeds; Belief or attitudes concerning morality; Justified moral principles of obligations, rights, ideals |
|
Meta-Ethics |
Ethics beyond the physical world; Ethical reasons for things that have happened as the will of God |
|
Normative Ethics |
Golden Rule; Moral conduct in regulating what is right or wrong |
|
Applied Ethics |
Analysis of moral issues; Abortion, mercy killing, animal rights |
|
Virtue |
Moral behavior; Person having a sense of right or wrong |
|
Deontology |
Duty and obligation; Obligation over outcome; Morality based on rules |
|
Teleology |
If outcome is good, the action can be good regardless of motive; A reason for something in function of its purpose |
|
Waste |
Any discarded or disposable material |
|
Infectious |
Waste contains pathogenic microbes |
|
Pathologic |
Waste contains human or animal tissue, organs, body parts or fluid |
|
Chemical |
Waste contains chemicals from laboratory work |
|
Radioactive |
Waste contains radioactive substance |
|
Biomedical |
Waste generated from diagnostic laboratories |
|
Hazardous Waste |
Potentially harmful or dangerous to health and/or environment |
|
Waste Management |
Aims to prevent the spread of disease and release of hazardous chemicals into environment |
|
Incineration |
Combustion with oxygen at high temperature |
|
Pyrolysis/Gasification |
Heating of waste with little to no oxygen |
|
Sterilization/Autoclave |
Saturated steam to eliminate microbes |
|
Sewage |
Selected wastes may be disposed into sewer treatment |
|
Biological Agents |
Have potential to post a threat to public health and safety; Bacteria, virus, fungi and parasites; Affect humans, animald and plants |
|
Group 1 |
Risk group classification that unlikely to cause disease |
|
Group 2 |
Risk group classification that can cause disease to humans; May be hazard to employees; Unlikely to spread to community; Prophylaxis/treatment available |
|
Group 3 |
Risk group classification that can cause severe disease to humans; May be serious hazard to employees; May spread to community; Prophylaxis/treatment available |
|
Group 4 |
Risk group classification that causes severe disease to humans; Serious hazard to employees; Likely to spread to community; Prophylaxis/treatment not readily available |